Skip to main content
. 2024 Sep 14;7(1):193–205. doi: 10.1159/000539754

Table 4.

Adverse effects in adults with UAD (n = 24) treated with CBD during the follow-up

Adverse effect Frequency (n) Percentage (%)
Dry mouth 8 33.33
Dizziness 8 33.33
Somnolence 8 33.33
Headache 6 25.00
Orthostatic hypotension 4 16.66
Diarrhea 2 8.33
Fatigue 2 8.33
Tachycardia 2 8.33
Elevated liver function test 1 4.17
Cannabinoid hyperemesis syndrome 1 4.17